A nested case-control study revealed that women in the upper tertial of FABP4 levels in the first and second trimesters had 5.3% and 44.7% higher risk of developing GDM respectively, compared to those in the lowest tertial [39]. This evidence concerns the gene FABP4 and gestational diabetes.